Spots Global Cancer Trial Database for Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization

Official Title: Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization Via Pressure-Enabled Drug Delivery With the TriNav Infusion System (PEDD-UFE)

Study ID: NCT06106633

Conditions

Uterine Bleeding

Uterine Fibroid

Interventions

TriNaV

Study Description

Brief Summary: The goal of this study is to assess of Pressure-Enabled Drug Delivery on fibroid treatment in patients undergoing UFE.

Detailed Description: Uterine fibroids are the most common tumor type in women of reproductive age and may be associated with abnormal menstrual bleeding, pain, sub-fertility, and diminished quality of life. For women interested in uterine preservation who want to derive adequate relief from medical management, uterine fibroid embolization (UFE) is a treatment option. The goal of this study is to assess of Pressure-Enabled Drug Delivery on fibroid treatment in patients undergoing UFE.